Patexia Logo
Patexia Logo
Products
  • IP Intelligence Reports
  • Patexia Concierge
  • Patent Analyzer
  • Trademarks Analyzer
  • Litigation Analyzer
  • All Products
Services
  • Lateral Opportunities
  • Expert Witness
  • Research Studies
  • Strategic Partnership
  • All Services
IP Community
  • IP Community
  • IP Webinars
  • In the News
Company
  • About Us
  • Press Release
  • Careers
  • Contact Us
Login
JoinBook a Meeting
Patexia Logo
Products
  • IP Intelligence Reports
  • Patexia Concierge
  • Patent Analyzer
  • Trademarks Analyzer
  • Litigation Analyzer
Services
  • Lateral Opportunities
  • Expert Witness
  • Research Studies
  • Strategic Partnership
Company
  • About Us
  • Press Release
  • Careers
  • Contact Us
Resources
  • IP Community
  • IP Webinars
  • In the News
  • Help Center
Contact
  • (310) 909-7611
  • 100 Wilshire Blvd. Suite 700
    Santa Monica, CA 90401 USA
  • info@patexia.com
  • Send a message
Follow Us
Terms and Conditions|Privacy Policy
© 2010-2023 Patexia Inc. All Rights Reserved.
Back to All Articles
Browse articles with tag: Biotech
You must be logged in to create a new article
All Articles
Knobbe Martens
6 days ago
•
Patent Litigation
Settlements Don’t Close the Door: Antitrust Claims Follow IPR Challenges in Life Sciences
Written by: Kenneth O. Aruda, Ph.D. & Jason J. Jardine In the ongoing case of Carefirst of Maryland Inc. v. Johnson... Read More
Knobbe Martens
Nov 13, 2024
New Tool From EPA, FDA, and USDA Guides Developers of Genetically Modified Microorganisms Through Regulatory Landscape
Written by: Susan M. Janicki, Ph.D. & Robert J. Hilton, Ph.D. On October 2, 2024, the U.S. Department of Agriculture (USDA),... Read More
Knobbe Martens
Oct 15, 2024
Nobel Prize in Medicine Awarded to American Scientists for Discovery of microRNA
Written by: Ashley C. Morales & Jane Dai, Ph.D. On October 7, 2024, the 2024 Nobel Prize in Physiology or Medicine... Read More
Knobbe Martens
Sep 16, 2024
FDA Approves Colony Stimulating Factor-1 Receptor (Csf-1R) Blocking Antibody for Treatment of Chronic Graft-Versus-Host Disease (Cgvhd)
Written by: Makoto Tsunozaki, Ph.D. & Jason J. Jardine On August 14, 2024, the U.S. Food and Drug Administration (FDA) approved... Read More
Knobbe Martens
Sep 16, 2024
FDA Approves Colony Stimulating Factor-1 Receptor (Csf-1R) Blocking Antibody for Treatment of Chronic Graft-Versus-Host Disease (Cgvhd)
Written by: Makoto Tsunozaki, Ph.D. & Jason J. Jardine On August 14, 2024, the U.S. Food and Drug Administration (FDA) approved... Read More
Knobbe Martens
Sep 6, 2024
Science Group Sues FDA Over New Laboratory-Developed Test Rule
Written by: Alistair J. McIntyre & Agnes Juang, Ph.D. On August 19, 2024, the Association for Molecular Pathology (AMP) sued the... Read More
  • <
  • 1
  • 2
  • ...
  • 27
  • >